Previous Article | Next Article ![]()
Journal of Virology, April 2007, p. 4186-4198, Vol. 81, No. 8
0022-538X/07/$08.00+0 doi:10.1128/JVI.02601-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

and
Jean Rommelaere1,
Infection and Cancer Program, Division F010 and INSERM Unit 701, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany,1 Department of Neurosurgery, University of Heidelberg, 69120 Heidelberg, Germany,2 Department of Neurosurgery, University Hospital of Freiburg, 79106 Freiburg, Germany,3 Institute of Physiological Chemistry, Martin Luther University Halle-Wittenberg, 06108 Halle, Germany4
Received 24 November 2006/ Accepted 30 January 2007
Gliomas are often resistant to the induction of apoptotic cell death as a result of the development of survival mechanisms during astrocyte malignant transformation. In particular, the overexpression of Bcl-2-family members interferes with apoptosis initiation by DNA-damaging agents (e.g., cisplatin) or soluble death ligands (e.g., TRAIL). Using low-passage-number cultures of glioma cells, we have shown that parvovirus H-1 is able to induce death in cells resistant to TRAIL, cisplatin, or both, even when Bcl-2 is overexpressed. Parvovirus H-1 triggers cell death through both the accumulation of lysosomal cathepsins B and L in the cytosol of infected cells and the reduction of the levels of cystatin B and C, two cathepsin inhibitors. The impairment of either of these effects protects glioma cells from the viral lytic effect. In normal human astrocytes, parvovirus H-1 fails to induce a killing mechanism. In vivo, parvovirus H-1 infection of rat glioma cells intracranially implanted into recipient animals triggers cathepsin B activation as well. This report identifies for the first time cellular effectors of the killing activity of parvovirus H-1 against malignant brain cells and opens up a therapeutic approach which circumvents their frequent resistance to other death inducers.
Published ahead of print on 7 February 2007.
L.D. and J.R. contributed equally to the work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»